Federal Food, Drug, and Cosmetic Act

Federal Food, Drug, and Cosmetic Act is a foundational United States law that provides the core legal framework for the regulation of consumer safety for a wide range of products. Enacted in 1938, it significantly expanded the authority of the Food and Drug Administration beyond the earlier Pure Food and Drug Act of 1906. The law established new standards for safety, mandated pre-market approval for new drugs, and brought cosmetics and medical devices under federal oversight for the first time.

Background and legislative history

The push for stronger legislation was catalyzed by a public health tragedy known as the Elixir Sulfanilamide incident of 1937, where a toxic solvent in a marketed drug caused over 100 deaths. This disaster exposed the fatal weaknesses of the 1906 law, which did not require proof of safety before a drug could be sold. Legislative efforts, championed by Senator Royal S. Copeland and supported by the FDA's chief, Walter G. Campbell, had been stalled for years in Congress. The public outcry following the Elixir Sulfanilamide disaster, combined with advocacy from figures like Harvey W. Wiley, finally propelled the bill to passage. It was signed into law by President Franklin D. Roosevelt on June 25, 1938.

Major provisions and requirements

The law introduced transformative requirements, most notably mandating that new drugs be proven safe for use before marketing, a process overseen by the Food and Drug Administration. It established legally enforceable standards of identity, quality, and fill-of-container for foods. The act prohibited the addition of poisonous substances to foods and mandated tolerances for unavoidable toxins. It extended regulatory authority to cosmetics and therapeutic devices, banning adulterated or misbranded products. Key sections also required that drug labels include adequate directions for use and warnings about potential habit-forming properties.

Enforcement and regulatory authority

Primary enforcement authority was granted to the Food and Drug Administration, then part of the United States Department of Agriculture. The act provided the FDA with critical tools, including the power to conduct factory inspections and to seek court injunctions against violative products. It authorized the United States Department of Justice to pursue criminal prosecutions against firms and individuals for violations. Subsequent interpretations by courts, such as the Supreme Court of the United States in cases like United States v. Dotterweich, affirmed that corporate officers could be held strictly liable for violations occurring under their watch.

Amendments and related legislation

The act has been amended numerous times to address evolving public health challenges. Major amendments include the Durham-Humphrey Amendment of 1951, which defined the distinction between prescription and over-the-counter drugs. The Food Additives Amendment of 1958, including the Delaney Clause, and the Color Additive Amendments of 1960, established pre-market approval for additives. The Kefauver-Harris Amendments of 1962, spurred by the thalidomide tragedy, added the requirement that drugs be proven effective. Other critical updates include the Medical Device Amendments of 1976, the Orphan Drug Act, and the Dietary Supplement Health and Education Act of 1994.

Impact and legacy

The law fundamentally reshaped consumer protection in the United States, creating the modern system of drug regulation and establishing the Food and Drug Administration as a preeminent global regulatory agency. Its requirement for pre-market proof of safety set a model later adopted by agencies like the European Medicines Agency. The act's framework directly influenced subsequent global harmonization efforts through the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. It remains the central statutory authority governing the safety of the nation's food supply, pharmaceuticals, cosmetics, and medical devices, impacting the operations of corporations from Pfizer to Procter & Gamble.

Category:United States federal food and drug legislation Category:1938 in American law Category:75th United States Congress